Form 4: LMAT Senior VP Sells Shares Under 10b5-1 Plan

Lemaitre Vascular Senior VP of Operations, Trent G. Kamke, sold 2,928 shares of common stock for approximately $107 per share under a pre-arranged trading plan.

Summary

• Trent G. Kamke, Senior V. P., Operations of Lemaitre Vascular Inc. (LMAT), reported a sale of common stock.
• The transaction involved the disposition of 2,928 shares of common stock.
• The shares were sold at a weighted average price of $106.9969 per share, with individual trades ranging from $105.32 to $107.46.
• The transaction occurred on May 8, 2026.
• Following this transaction, Trent G. Kamke beneficially owns 3,749 shares of common stock directly.
• The sale was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly negative event. While it's an insider sale, the execution under a 10b5-1 plan mitigates concerns about opportunistic selling, suggesting a pre-planned financial management decision rather than a reaction to new company-specific information.

Positives

• The transaction was conducted under a Rule 10b5-1 trading plan, which indicates the sale was pre-scheduled and not based on immediate, non-public information, enhancing transparency.

Negatives

• An insider sale, even under a 10b5-1 plan, reduces the executive's direct equity stake in the company, which some investors might interpret as a slight reduction in alignment of interests or a belief that the current stock price is favorable for selling.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it is a report of a past transaction.

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under Rule 10b5-1 plans, are a common practice for executives managing personal finances, diversifying portfolios, or exercising stock options. Such transactions are generally viewed as routine and do not necessarily signal a change in the company's fundamental outlook, especially when pre-arranged.

Stakeholder Impact

• Shareholders: The sale by a Senior VP could be interpreted by some shareholders as a minor reduction in management's direct equity alignment, though the 10b5-1 plan lessens this concern.

Key Dates

Recommendation

A single insider sale, particularly when executed under a Rule 10b5-1 plan, typically does not provide a strong enough signal to warrant a 'buy' or 'sell' recommendation. Such transactions are often for personal financial planning and do not necessarily reflect a change in the company's fundamental prospects. Investors should 'hold' and consider this transaction in the broader context of the company's financial performance and strategic initiatives.

Keywords

LEMAITRE VASCULAR, LMAT, Insider Trading, Form 4, Stock Sale, Trent G. Kamke, 10b5-1 Plan